WORKSHOP 2 - Autoimmune Bullous Diseases

10:05 • WS2_1 • Double blind double dummy randomised control trial comparing rituximab versus cyclophosphamide in severe types of mucous membrane pemphigoid > P. Pascal JOLY (Rouen) 10:35 • WS2_2 • The contribution of keratinocytes in responses to autoantibodies in Bullous pemphigoid > M. Manuela PIGORS (Lübeck) 11:05 • WS2_3 • Autoreactive Treg in Pemphigus > H. Hayato TAKAHASHI (Tokyo)